Anton, B., Salazar, A., Florez, A., Matus, M., Marin, R., & Hernandez, J.-A. (2009). Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Human Vaccines, 5(4), 214–229. https://doi.org/https://doi.org/10.4161/hv.5.4.7556

  
Barrientos, R. C., Bow, E. W., Whalen, C., Torres, O. B., Sulima, A., Beck, Z., Jacobson, A. E., Rice, K. C., & Matyas, G. R. (2020). Novel vaccine that blunts fentanyl effects and sequesters ultrapotent fentanyl analogues. Molecular Pharmaceutics, 17(9), 3447–3460. https://doi.org/https://doi.org/10.1021/acs.molpharmaceut.0c00497  

Barrientos, R. C., Whalen, C., Torres, O. B., Sulima, A., Bow, E. W., Komla, E., Beck, Z., Jacobson, A. E., Rice, K. C., & Matyas, G. R. (2021). Bivalent conjugate vaccine induces dual immunogenic response that attenuates heroin and fentanyl effects in mice. Bioconjugate Chemistry, 32(11), 2295–2306. https://doi.org/10.1021/acs.bioconjchem.1c00179   

Bremer, P. T., & Janda, K. D. (2017). Conjugate Vaccine Immunotherapy for Substance 
Use Disorder. Pharmacological reviews, 69(3), 298–315. https://doi.org/10.1124/pr.117.013904 

Cai, X., Whitfield, T., Moreno, A. Y., Grant, Y., Hixon, M. S., Koob, G. F., & Janda, K. D. 
(2013). Probing the effects of hapten stability on cocaine vaccine immunogenicity. 
Molecular pharmaceutics, 10(11), 4176–4184. https://doi.org/10.1021/mp400214w 

CDC. (2021, March 17). Understanding the Epidemic. Centers for Disease Control and Prevention. Retrieved January 24, 2022, from https://www.cdc.gov/opioids/basics/epidemic.html  

Columbia University. (2021, August 30). Experimental Opioid Vaccine Being Tested at Columbia. Columbia University Irving Medical Center. Retrieved January 24, 2022, from https://www.cuimc.columbia.edu/news/experimental-opioid-vaccine-being-tested-columbia  

Ernst, D. (2018, December 12). CDC: Top 10 drugs involved in drug overdose deaths. MPR. Retrieved January 24, 2022, from https://www.empr.com/home/news/cdc-top-10-drugs-involved-in-drug-overdose-deaths/  

Furfaro, H. (2022, January 5). To fight opioid crisis, UW researchers take new shot at developing vaccine against addictive drugs. The Seattle Times. Retrieved January 24, 2022, from https://www.seattletimes.com/seattle-news/mental-health/to-fight-opioid-crisis-uw-researchers-take-new-shot-at-developing-vaccine-against-addictive-drugs/  

Gabrielle, V. (2021, October 5). Why monoclonal antibodies are expensive and hard to make in the fight against COVID-19. Knox News. Retrieved January 24, 2022, from https://www.knoxnews.com/story/news/2021/10/04/monoclonal-antibodies-expensive-hard-manufacture-covid-coronavirus/5887418001/ 

Gammon, K. (2017, April 24). Anti-drug vaccines could be a game-changer for people battling addiction. NBC News. Retrieved January 24, 2022, from https://www.nbcnews.com/mach/science/anti-drug-vaccines-could-be-game-changer-people-battling-addiction-n749416

 
Georgetown Behavioral Health Institute. (2018, August 14). The Origin and Causes of the 
Opioid Epidemic. Georgetown Behavioral Health Institute. Retrieved January 24, 2022, from https://www.georgetownbehavioral.com/blog/origin-and-causes-of-opioid-epidemic  

HealthCare Resource Centers Clinical Team. (2020, January 27). Methadone vs. Buprenorphine: Similarities and Differences. HCRC. Retrieved January 24, 2022, from https://www.hcrcenters.com/blog/methadone-vs-buprenorphine-similarities-differences-hcrc/ 

InvivoGen. (2022, January 18). Alhydrogel® Adjuvant 2%. InvivoGen. Retrieved January 24, 2022, from https://www.invivogen.com/alhydrogel  
Jones, M. R., Viswanath, O., Peck, J., Kaye, A. D., Gill, J. S., & Simopoulos, T. T. 
(2018). A Brief History of the Opioid Epidemic and Strategies for Pain Medicine. Pain and therapy, 7(1), 13–21. https://doi.org/10.1007/s40122-018-0097-6 

Kinsey B. (2014). Vaccines against drugs of abuse: where are we now?. Therapeutic advances in vaccines, 2(4), 106–117. https://doi.org/10.1177/2051013614537818 

MacGuill, D. (2021, December 21). Did fentanyl overdose become top cause of death for adults aged 18-45 in the US? Snopes. Retrieved January 24, 2022, from https://www.snopes.com/fact-check/fentanyl-overdose-death/  

Madras, B. K., Ahmad, N. J., Wen, J., & Sharfstein, J. (2020, April 27). Improving access to evidence-based medical treatment for opioid use disorder: Strategies to address key barriers within the treatment system. National Academy of Medicine. Retrieved January 24, 2022, from https://nam.edu/improving-access-to-evidence-based-medical-treatment-for-opioid-use-disorder-strategies-to-address-key-barriers-within-the-treatment-system/  

Mayo Foundation for Medical Education and Research. (2021, November 9). Monoclonal antibody drugs for cancer: How they work. Mayo Clinic. Retrieved January 24, 2022, from https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/monoclonal-antibody/art-20047808 

 

NIDA. (2016, February 22). Anti-Drug Vaccine Animation. National Institute on Drug Abuse. Retrieved January 24, 2022, from https://www.drugabuse.gov/news-events/nida-notes/anti-drug-vaccine-animation  

NIDA. (2021, April 13). How do medications to treat opioid use disorder work? National Institute on Drug Abuse. Retrieved January 24, 2022, from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/how-do-medications-to-treat-opioid-addiction-work  

NIDA. (2021, April 13). What is the treatment need versus the diversion risk for opioid use disorder treatment? National Institute on Drug Abuse. Retrieved January 24, 2022, from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/what-treatment-need-versus-diversion-risk-opioid-use-disorder-treatment  

NIDA. (2022, January 21). Medications to Treat Opioid Use Disorder Research Report: Overview. National Institute on Drug Abuse. Retrieved January 24, 2022, from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/overview  

NIDA. (2022, January 23). Naloxone for Opioid Overdose: Life-Saving Science. National Institute on Drug Abuse. Retrieved January 24, 2022, from https://www.drugabuse.gov/publications/naloxone-opioid-overdose-life-saving-science  

NIH HEAL Initiative. (2021, November 2). A Shot Against Opioids. National Institutes of Health. Retrieved January 24, 2022, from https://heal.nih.gov/news/stories/OUD-vaccine

Ogura, T., & Egan, T. D. (2019). Intravenous opioid agonists and antagonists. Pharmacology and 
Physiology for Anesthesia, 332–353. https://doi.org/10.1016/b978-0-323-48110-6.00017-x 

The Recovery Village. (2021, December 17). Commonly Abused Opiates. The Recovery Village. Retrieved January 24, 2022, from https://www.therecoveryvillage.com/opiate-addiction/which-opiates-are-most-commonly-abused/   

SAMSHA. (2021, July 8). Naloxone. SAMHSA. Retrieved January 24, 2022, from https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/naloxone   

Schlingmann, B., Castiglia, K. R., Stobart, C. C., & Moore, M. L. (2018). Polyvalent vaccines: High-maintenance heroes. PLOS Pathogens, 14(4). https://doi.org/10.1371/journal.ppat.1006904   

Spector, S., & Parker, C. W. (1970). Morphine: Radioimmunoassay. Science, 168(3937), 
1347–1348. https://doi.org/10.1126/science.168.3937.1347  

van Dorp, E., Yassen, A., & Dahan, A. (2007). Naloxone treatment in opioid addiction: the risks and benefits. Expert opinion on drug safety, 6(2), 125–132. https://doi.org/10.1517/14740338.6.2.125

​

All images are self-created or Vector Art from Wix.com.